Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer-论文-万方医学网

首页> > Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer

Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer

导出原文传递

翻译打印收藏纠错

第一作者： Bright, John R.

作者： Bright, John R. ^[1] ; Lis, Rosina T. ^[2] ; Ku, Anson T. ; Terrigino, Nicholas T. ; Whitlock, Nichelle C. ; Trostel, Shana Y. ; Carrabba, Nicole, V ; Harmon, Stephanie A. ; Turkbey, Baris ; Wilkinson, Scott ; Sowalsky, Adam G.

作者单位： Lab Genitourinary Canc Pathogenesis,NCI ^[1] Mol Imaging Branch,NCI ^[2]

关键词 prostatic neoplasms neoadjuvant therapy immunohistochemistry pathology RADICAL PROSTATECTOMY RISK ADENOCARCINOMA CLASSIFICATION EXPRESSION

发布时间 2022-08-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer

相似文献

同项目论文

相关期刊

检索历史 清除

Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer

相似文献

同项目论文

相关期刊

检索历史清除